TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Artivion ( (AORT) ) has issued an announcement.
On September 26, 2025, Artivion, Inc. entered into two real estate purchase agreements to acquire properties in Austin, Texas. The first agreement involves purchasing two office buildings for $12.05 million, which currently house the company’s On-X manufacturing operations. The second agreement is for an adjacent property, costing $8.45 million, to expand their operational footprint. Both agreements include feasibility periods allowing Artivion to inspect the properties before finalizing the purchases, with closings expected within 30 days post-feasibility period.
The most recent analyst rating on (AORT) stock is a Buy with a $46.00 price target. To see the full list of analyst forecasts on Artivion stock, see the AORT Stock Forecast page.
Spark’s Take on AORT Stock
According to Spark, TipRanks’ AI Analyst, AORT is a Neutral.
Artivion’s overall score is driven by strong earnings call results and positive corporate events, but is weighed down by financial performance challenges and lack of technical analysis data.
To see Spark’s full report on AORT stock, click here.
More about Artivion
Artivion, Inc. operates in the manufacturing industry, focusing on producing medical devices and equipment. The company is known for its On-X manufacturing operation, which is a significant part of its business.
Average Trading Volume: 460,704
Technical Sentiment Signal: Buy
Current Market Cap: $1.94B
Learn more about AORT stock on TipRanks’ Stock Analysis page.